AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8384388 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (Fragmin) 5,000 IU subcutaneously once daily for six days, starting preoperatively
Number of subjects: 82
Study 8384388 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 3529801 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 hours exposure to humidified nitrogen gas (anoxia)
Number of subjects: 9
Study 30290627 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal intubation
Number of subjects: 134
Study 30290627 — intervention group
Group type: EXPERIMENTAL
Intervention: Air‐Q
Number of subjects: 134
Study 30290627 — intervention group
Group type: EXPERIMENTAL
Intervention: I‐Gel
Number of subjects: 134
Study 27128496 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone (1 mg/mL)
Number of subjects: 82
Study 27128496 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl (15 μg/mL)
Number of subjects: 82
Study 24738793 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrowband ultraviolet B (NBUVB) plus methotrexate (MTX)
Number of subjects: 113
Study 24738793 — intervention group
Group type: COMPARATOR
Intervention: Narrowband ultraviolet B (NBUVB) alone
Number of subjects: 113
Study 24738793 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) alone
Number of subjects: 113
Study 22762290 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreatin (Creon 40000 MMS)
Number of subjects: 62
Study 22762290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 20558909 — intervention group
Group type: EXPERIMENTAL
Intervention: efonidipine 20-60 mg twice daily
Number of subjects: 20
Study 20558909 — intervention group
Group type: COMPARATOR
Intervention: amlodipine 2.5-7.5 mg once daily
Number of subjects: 20
Study 18459154 — intervention group
Group type: EXPERIMENTAL
Intervention: 41 degrees C footbath for 40 minutes before sleep onset
Number of subjects: 15
Study 18459154 — intervention group
Group type: COMPARATOR
Intervention: Control (no footbath)
Number of subjects: 15
Study 16024209 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained counselors
Number of subjects: 158
Study 16024209 — intervention group
Group type: COMPARATOR
Intervention: Untrained counselors
Number of subjects: 158
Study 12884545 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (500 mg daily in pellets for 8 to 12 hours)
Number of subjects: 76
Study 12884545 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation
Number of subjects: 76
Study 12884545 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vitamin C supplementation)
Number of subjects: 76
Study 10871560 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g oat bran concentrate (OBC; containing 3 g beta-glucan)
Number of subjects: 62
Study 10871560 — intervention group
Group type: COMPARATOR
Intervention: 20 g wheat bran (control)
Number of subjects: 62
Study 9192129 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobics training (20-25 minutes, three times a week for eight weeks)
Number of subjects: 51
Study 9192129 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycle ergometer training (20 minutes at 160-170 beats/minute, three times a week for eight weeks)
Number of subjects: 51
Study 9192129 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 51
Study 1555902 — intervention group
Group type: EXPERIMENTAL
Intervention: Category Ratio Scale (CR-10)
Number of subjects: 24
Study 1555902 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Analogue Scale (VAS)
Number of subjects: 24
Study 1555902 — intervention group
Group type: COMPARATOR
Intervention: Magnitude Estimation (ME)
Number of subjects: 24
Study 3878659 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) at 2 Hz
Number of subjects: 12
Study 3878659 — intervention group
Group type: COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation (TENS) at 100 Hz
Number of subjects: 12
Study 3878659 — intervention group
Group type: COMPARATOR
Intervention: Vibration at 100 Hz
Number of subjects: 12
Study 3878659 — intervention group
Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 12
Study 3878659 — intervention group
Group type: COMPARATOR
Intervention: All types of conditioning stimulation
Number of subjects: 12
Study 30399092 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial ultrasound examinations every 4 weeks
Number of subjects: 206
Study 30399092 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control arm)
Number of subjects: 206
Study 30399092 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial ultrasound examinations
Number of subjects: 206
Study 26211415 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 38
Study 26211415 — intervention group
Group type: COMPARATOR
Intervention: Standard social support (SS)
Number of subjects: 38
Study 25237186 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C
Number of subjects: 12
Study 25237186 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 12
Study 22321402 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-curved rocker sole shoe
Number of subjects: 8
Study 22321402 — intervention group
Group type: COMPARATOR
Intervention: Baseline (no intervention)
Number of subjects: 8
Study 19625274 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0
Study 18846777 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine 20 mg (single dose)
Number of subjects: 55
Study 18846777 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (12 weeks)
Number of subjects: 55
Study 18846777 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg/day (for one week)
Number of subjects: 55
Study 16422308 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard group sequential methods
Number of subjects: 0
Study 14750352 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Rhino Goodman pack
Number of subjects: 14
Study 14750352 — intervention group
Group type: COMPARATOR
Intervention: Merocel pack
Number of subjects: 14
Study 10353573 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic beclomethasone 42 microg
Number of subjects: 518
Study 10353573 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic beclomethasone 84 microg
Number of subjects: 518
Study 10353573 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic beclomethasone 42 microg and 84 microg
Number of subjects: 518
Study 10353573 — intervention group
Group type: COMPARATOR
Intervention: Generic beclomethasone
Number of subjects: 518
Study 10353573 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic beclomethasone and innovator beclomethasone
Number of subjects: 518
Study 7555212 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime (group CAZ)
Number of subjects: 128
Study 7555212 — intervention group
Group type: EXPERIMENTAL
Intervention: Best guess combined antibiotic therapy (group COMB)
Number of subjects: 128
Study 7555212 — intervention group
Group type: COMPARATOR
Intervention: Open group with free combination of antibiotics (group OPEN)
Number of subjects: 128
Study 1934434 — intervention group
Group type: EXPERIMENTAL
Intervention: Low hemoglobin low flow warm blood cardioplegia (50 g/l, <80 ml/min)
Number of subjects: 35
Study 1934434 — intervention group
Group type: EXPERIMENTAL
Intervention: High hemoglobin high flow warm blood cardioplegia (80 g/l, >80 ml/min)
Number of subjects: 35
Study 1934434 — intervention group
Group type: COMPARATOR
Intervention: Intermittent cold blood cardioplegia
Number of subjects: 35
Study 1934434 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous normothermic cardioplegia (80 ml/min or greater, 80 g/l)
Number of subjects: 35
Study 7072624 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg iron once daily
Number of subjects: 621
Study 7072624 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg iron 3 times daily
Number of subjects: 621
Study 7072624 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg iron 3 times daily plus a 5‐mg folic acid tablet once daily
Number of subjects: 621
Study 7072624 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg iron 3 times daily plus a 5‐mg folic acid tablet once daily and weekly antimalarial prophylactic
Number of subjects: 621
Study 7072624 — intervention group
Group type: COMPARATOR
Intervention: Untreated women (control group)
Number of subjects: 621
Study 31917731 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept 2 mg every 4 weeks (2q4)
Number of subjects: 40
Study 31917731 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal aflibercept 2 mg every 12 weeks (2q12)
Number of subjects: 40
Study 30896648 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval (HII) exercise for 8 weeks
Number of subjects: 32
Study 30896648 — intervention group
Group type: COMPARATOR
Intervention: Control group (medications without exercise)
Number of subjects: 32
Study 28495347 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinedie clinical decision support system
Number of subjects: 90
Study 26866933 — intervention group
Group type: EXPERIMENTAL
Intervention: Transanal submucosal injection of polyacrylamide hydrogel
Number of subjects: 30
Study 24717710 — intervention group
Group type: EXPERIMENTAL
Intervention: DentalVibe Injection Comfort System
Number of subjects: 36
Study 24717710 — intervention group
Group type: COMPARATOR
Intervention: Traditional injection without the aid of the DentalVibe
Number of subjects: 36
Study 21938381 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide 20 μg/day
Number of subjects: 0
Study 21938381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18608553 — intervention group
Group type: EXPERIMENTAL
Intervention: β‐lactoglobulin‐enriched WPI
Number of subjects: 8
Study 18608553 — intervention group
Group type: EXPERIMENTAL
Intervention: WPI
Number of subjects: 8
Study 18608553 — intervention group
Group type: EXPERIMENTAL
Intervention: All protein drinks
Number of subjects: 8
Study 18608553 — intervention group
Group type: COMPARATOR
Intervention: Hydrolysed WPI
Number of subjects: 8
Study 18608553 — intervention group
Group type: COMPARATOR
Intervention: Flavour‐identical control
Number of subjects: 8
Study 17499695 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic transcricothyroid ultrasonography (US)
Number of subjects: 7
Study 17499695 — intervention group
Group type: EXPERIMENTAL
Intervention: Static transcricothyroid ultrasonography (US)
Number of subjects: 7
Study 15202930 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (600 mg)
Number of subjects: 20
Study 15202930 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (1000 mg)
Number of subjects: 20
Study 15202930 — intervention group
Group type: COMPARATOR
Intervention: Nitric oxide donor and sodium nitroprusside (control)
Number of subjects: 20
Study 11772772 — intervention group
Group type: EXPERIMENTAL
Intervention: STD/HIV behavior change intervention
Number of subjects: 604
Study 9693241 — intervention group
Group type: EXPERIMENTAL
Intervention: Piritramide (0.1‐0.3 mg/kg) and midazolam (1‐3 mg) i.v.
Number of subjects: 95
Study 9693241 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine/prilocaine cream (30 g) topically and diclofenac suppository (100 mg)
Number of subjects: 95
Study 9693241 — intervention group
Group type: COMPARATOR
Intervention: No analgesia
Number of subjects: 95
Study 7662079 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefcanel 300 mg tablets twice daily
Number of subjects: 354
Study 7662079 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor 250 mg capsules three times daily
Number of subjects: 354
Study 2547256 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic anti-CMV immunoglobulin administration
Number of subjects: 39
Study 325837 — intervention group
Group type: EXPERIMENTAL
Intervention: IR regimen (isoniazid and rifampicin for 3 months followed by isoniazid and either streptomycin or ethambutol for 6 months)
Number of subjects: 232
Study 325837 — intervention group
Group type: EXPERIMENTAL
Intervention: ISE regimen (isoniazid, streptomycin and ethambutol for 3 months followed by isoniazid and either streptomycin or ethambutol for 6 months)
Number of subjects: 232
Study 325837 — intervention group
Group type: COMPARATOR
Intervention: Both regimens
Number of subjects: 232
Study 31805854 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 35
Study 31805854 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 35
Study 27669664 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewed oxycodone DETERx
Number of subjects: 38
Study 27669664 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact oxycodone DETERx
Number of subjects: 38
Study 27669664 — intervention group
Group type: COMPARATOR
Intervention: Crushed immediate-release oxycodone
Number of subjects: 38
Study 25698069 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal information condition
Number of subjects: 160
Study 25698069 — intervention group
Group type: EXPERIMENTAL
Intervention: Approach‐avoidance training
Number of subjects: 160
Study 25698069 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined condition (verbal information + approach‐avoidance training)
Number of subjects: 160
Study 25698069 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined condition (approach‐avoidance training + verbal information)
Number of subjects: 160
Study 24174625 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Number of subjects: 219
Study 24174625 — intervention group
Group type: COMPARATOR
Intervention: Best Available Therapy (BAT)
Number of subjects: 219
Study 21341958 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio HIV/AIDS prevention intervention
Number of subjects: 210
Study 21341958 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 210)
Number of subjects: 210
Study 18539340 — intervention group
Group type: EXPERIMENTAL
Intervention: Titrated RUL ECT at 2.25 times initial seizure threshold
Number of subjects: 72
Study 18539340 — intervention group
Group type: COMPARATOR
Intervention: RUL ECT at a fixed dose of 403 mC
Number of subjects: 72
Study 17950161 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug and Alcohol Testing (DAT)
Number of subjects: 11
Study 17950161 — intervention group
Group type: COMPARATOR
Intervention: Deferred Policy
Number of subjects: 11
Study 15528176 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 45
Study 15528176 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 45
Study 11436683 — intervention group
Group type: EXPERIMENTAL
Intervention: Infectious mononucleosis patients
Number of subjects: 42
Study 11436683 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 42
Study 9895420 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetarians
Number of subjects: 38
Study 9895420 — intervention group
Group type: COMPARATOR
Intervention: Nonvegetarians
Number of subjects: 38
Study 7823232 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (physicians received reports summarizing patients' responses)
Number of subjects: 497
Study 7823232 — intervention group
Group type: COMPARATOR
Intervention: Control group (physicians received no report)
Number of subjects: 497
Study 2828412 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxyvitamin D (0.5 micrograms daily)
Number of subjects: 8
Study 2828412 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 8
Study 2828412 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxyvitamin D (1 microgram daily) in a hypoparathyroid patient
Number of subjects: 8
Study 31541942 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorogenic acid for injection (CAFI) administered intramuscularly
Number of subjects: 0
Study 29710125 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible sigmoidoscopy screening (with and without additional fecal blood testing)
Number of subjects: 98678
Study 26957044 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor residual spraying and long-lasting insecticidal nets (not specified dosage or duration)
Number of subjects: 5309
Study 25039678 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo care with maternal singing
Number of subjects: 86
Study 25039678 — intervention group
Group type: COMPARATOR
Intervention: Kangaroo care without maternal singing
Number of subjects: 86
Study 22367645 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab exposure during pregnancy (group 1)
Number of subjects: 70
Study 22367645 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab exposure >3 months after last dose (group 2)
Number of subjects: 70
Study 22367645 — intervention group
Group type: COMPARATOR
Intervention: No prior exposure to trastuzumab (group 3)
Number of subjects: 70
Study 20543266 — intervention group
Group type: EXPERIMENTAL
Intervention: VR and Mobile group with biofeedback (VRMB)
Number of subjects: 20
Study 20543266 — intervention group
Group type: EXPERIMENTAL
Intervention: VR and Mobile group without biofeedback (VRM)
Number of subjects: 20
Study 20543266 — intervention group
Group type: COMPARATOR
Intervention: Waiting list group (WL)
Number of subjects: 20
Study 18031745 — intervention group
Group type: EXPERIMENTAL
Intervention: Drotaverine hydrochloride
Number of subjects: 150
Study 18031745 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine‐N‐butylbromide
Number of subjects: 150
Study 18031745 — intervention group
Group type: COMPARATOR
Intervention: No medication (Control)
Number of subjects: 150
Study 15927302 — intervention group
Group type: EXPERIMENTAL
Intervention: Squire's Quest! intervention (10-session psychoeducational multimedia game)
Number of subjects: 26
Study 15927302 — intervention group
Group type: EXPERIMENTAL
Intervention: Squire's Quest! intervention
Number of subjects: 26
Study 15927302 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 26
Study 14979427 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose aprotinin
Number of subjects: 0
Study 14979427 — intervention group
Group type: COMPARATOR
Intervention: Aprotinin
Number of subjects: 0
Study 14979427 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 11801931 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.15-1.0 mg/kg; maximum dose 8-25 mg)
Number of subjects: 8
Study 11801931 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 9439409 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter-valve
Number of subjects: 100
Study 9439409 — intervention group
Group type: COMPARATOR
Intervention: Standard drainage system
Number of subjects: 100
Study 7694306 — intervention group
Group type: EXPERIMENTAL
Intervention: risperidone 2‐20 mg daily
Number of subjects: 62
Study 7694306 — intervention group
Group type: COMPARATOR
Intervention: haloperidol 2‐20 mg daily
Number of subjects: 62
Study 7694306 — intervention group
Group type: COMPARATOR
Intervention: haloperidol
Number of subjects: 62
Study 7694306 — intervention group
Group type: EXPERIMENTAL
Intervention: risperidone
Number of subjects: 62
Study 3123607 — intervention group
Group type: EXPERIMENTAL
Intervention: R-(-)-deprenyl
Number of subjects: 30
Study 3123607 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of levodopa with deprenyl
Number of subjects: 30
Study 29689116 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide administration
Number of subjects: 3228
Study 29689116 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide bolus(es) as a preventive measure
Number of subjects: 3228
Study 29689116 — intervention group
Group type: COMPARATOR
Intervention: Control group (any comparator)
Number of subjects: 3228
Study 25856220 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic group received a daily capsule containing 10(8) CFUs of Lactobacillus casei 01 for 8 weeks.
Number of subjects: 46
Study 25856220 — intervention group
Group type: COMPARATOR
Intervention: Placebo group received identical capsules containing maltodextrin for 8 weeks.
Number of subjects: 46
Study 26215206 — intervention group
Group type: EXPERIMENTAL
Intervention: High stroke volume variation group (maintaining 10‐20% of stroke volume variation)
Number of subjects: 78
Study 26215206 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintaining < 10% stroke volume variation)
Number of subjects: 78
Study 23902783 — intervention group
Group type: EXPERIMENTAL
Intervention: Variety of vegetables (cucumber, sweet pepper, tomato)
Number of subjects: 61
Study 23902783 — intervention group
Group type: EXPERIMENTAL
Intervention: Variety of fruit (apple, peach, pineapple)
Number of subjects: 61
Study 23902783 — intervention group
Group type: COMPARATOR
Intervention: Single type of vegetables (cucumber, sweet pepper, or tomato)
Number of subjects: 61
Study 23902783 — intervention group
Group type: COMPARATOR
Intervention: Single type of fruit (apple, peach, or pineapple)
Number of subjects: 61
Study 20171055 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation (DHA and EPA)
Number of subjects: 450
Study 20171055 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450
Study 18266548 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine-containing supplement (200 mg)
Number of subjects: 35
Study 18266548 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 16507156 — intervention group
Group type: COMPARATOR
Intervention: Epinephrine
Number of subjects: 22
Study 16507156 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopexamine-norepinephrine
Number of subjects: 22
Study 12763515 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 0
Study 12763515 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational trials of HRT
Number of subjects: 0
Study 12763515 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized trials of HRT
Number of subjects: 0
Study 10890612 — intervention group
Group type: EXPERIMENTAL
Intervention: Small Intestinal (SI) feeding
Number of subjects: 44
Study 10890612 — intervention group
Group type: COMPARATOR
Intervention: Gastric (G) feeding
Number of subjects: 44
Study 8885254 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 31375619 — intervention group
Group type: EXPERIMENTAL
Intervention: paediatric Goal Management Training (pGMT)
Number of subjects: 80
Study 31375619 — intervention group
Group type: COMPARATOR
Intervention: psychoeducative control intervention (paediatric Brain Health Workshop)
Number of subjects: 80